Business and Innovation

Subspecialties Basic & Translational Research

05/30/2023 | Sponsored by Schwind | 4 min read

What sets Schwind’s ATOS platform above other femtosecond lasers on the market?

Business & Profession Professional Development

05/25/2023 | Imran Rahman | 4 min read

Incorporating technology and increased digitization is key to curbing the UK National Health Service’s crisis

Business & Profession Other

05/24/2023 | Stephen G. Schwartz, Christopher T. Leffler, Andrzej Grzybowski | 3 min read

One-Eyed Warriors: Horatio Nelson

Subspecialties Retina

05/22/2023 | Daan Panneman | 4 min read

A new cost-effective targeted sequencing panel may provide accessible and affordable genetic diagnoses for patients and clinicians the world over.

Business & Profession Business and Innovation

05/20/2023 | Jed Boye | 3 min read

We take a look back at the highlights and memorable moments of ARVO 2023

Business & Profession Health Economics and Policy

05/11/2023 | Jed Boye | 4 min read

What led to the recent bacterial outbreak in the USA that infected 68 and, resulted in the death of three patients?

Subspecialties Retina

05/10/2023 | Maria Znamenska | 2 min read

AI platform alleviates pressure of ophthalmologists

Business & Profession Basic & Translational Research

05/09/2023 | Jed Boye, Sarah Healey | 2 min read

Keep up to date with the latest research from ARVO journals through our breakdown

Subspecialties Retina

05/02/2023 | Sarah Healey | 5 min read

Is OkuStim the future of retinitis pigmentosa treatment?

Business & Profession Professional Development

04/25/2023 | John Berdahl | 3 min read

Why we must strive for more precise visualization systems and treatment approaches when it comes to primary open-angle glaucoma